Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Only 3% of shares needed to add nominee..... New SEC rule change !!

What is beneficial about comparing apples to oranges? Chevron had EARNINGS of over $10 Billion (with a B) last year, and positive cash flow from operations of over $19 billion enabling a dividend which yields 3.6%. In addition their stock has not declined 95% in the last 4 years. Not much a reason to question their BoD's abilities ............. ahh, perhaps there is reason in making certain comparisons.

Share
New Message
Please login to post a reply